RobertThomasKeenanMDMPH, MBA
Rheumatology • Florence, SCCrystal Related, Spondyloarthropathy, Vasculitis
Adjunct Associate Professor, Medicine, Duke University School of Medicine
Dr. Keenan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 E. Cheves St.
Suite 280
Florence, SC 29506Phone+1 843-973-8770Fax+1 843-428-2490
Education & Training
University of MassachusettsMBA, 2014 - 2017
NYU Grossman School of MedicineFellowship, Rheumatology, 2007 - 2009
SSM Health/Saint Louis University School of MedicineResidency, Internal Medicine, 2004 - 2007
St. George's University School of MedicineClass of 2004- University of North Carolina at Chapel HillMPH, 1998 - 2000
Certifications & Licensure
NC State Medical License 2009 - 2025
SC State Medical License 2020 - 2025
NY State Medical License 2007 - 2009
VA State Medical License 2007 - 2008
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- 7 citationsThe COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTOR™) versus pegloticase for refractory gout.Herbert S B Baraf, Puja P Khanna, Alan J Kivitz, Vibeke Strand, Hyon K Choi
Rheumatology. 2024-04-02 - 2 citationsPegloticase causes prolonged improvement in multiple disease parameters in patients with chronic refractory gout who maintain low serum urate levels.Robert T Keenan, Anthony E Yeo, Peter E Lipsky
Clinical and Experimental Rheumatology. 2022-05-01 - 4 citationsExpert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of Response.John K Botson, Herbert S B Baraf, Robert T Keenan, John Albert, Karim R Masri
Current Rheumatology Reports. 2022-01-01
Press Mentions
12 Myths About Gout That You Should Stop Believing NowMay 21st, 2021- Clinician Q&A: Can Immunomodulators Improve the Effect of Pegloticase in Uncontrolled Gout?April 2nd, 2021
What Is a Good Diet for Gout That Will Reduce Your Risk of Painful Flare-UpsFebruary 24th, 2020
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
